Recently, a medical corruption case has drawn widespread public attention: a hospital doctor accepted a bribe of 35,000 RMB from a pharmaceutical sales representative and prescribed specific drugs in excess, leading to nearly 1 million RMB in profits for the salesperson. This incident not only reveals the ethical shortcomings of certain medical professionals but also exposes the long-standing ‘kickback-driven sales’ practices within the pharmaceutical supply chain.According to investigations, the doctor knowingly overprescribed a drug that was overpriced and offered no significant therapeutic advantage, constituting the crime of bribery by non-state personnel. Meanwhile, the pharmaceutical company’s practice of offering kickbacks to influence prescriptions disrupted fair market competition, increased patient costs, and undermined the rational use of public healthcare resources.This is not an isolated case. In recent years, China’s National Health Commission and National Healthcare Security Administration have launched ongoing anti-corruption campaigns targeting commercial bribery in the medical sector. The 2023 ‘Opinions on Deepening Medical and Health System Reform’ explicitly calls for severing financial ties between drug sales and physician income, promoting transparent procurement and prescription practices.Experts emphasize that eradicating the entrenched practice of ‘using drugs to subsidize medical services’ requires systemic reforms—strengthening oversight, improving fair compensation mechanisms for healthcare workers, and enhancing professional ethics education. Only through a clean and trustworthy medical environment can patient rights and the integrity of the healthcare system be truly safeguarded.
近日，一起医疗腐败案件引发社会广泛关注：某医院医生因收受医药代表3.5万元回扣，违规开具特定药品处方，导致该药品销售额激增，使药企销售人员从中获利近100万元。这一事件不仅暴露了个别医务人员职业道德的缺失，也揭示了医药购销环节中长期存在的“带金销售”潜规则。根据调查，该医生在明知药品价格虚高、疗效并无显著优势的情况下，仍大量开具相关处方，其行为已构成非国家工作人员受贿罪。而药企通过给予回扣的方式诱导医生开药，不仅扰乱了公平竞争的市场秩序，也加重了患者负担，损害了公共医疗资源的合理使用。此类案件并非孤例。近年来，国家卫健委、医保局等部门持续开展专项整治行动，严厉打击医药领域商业贿赂行为。2023年出台的《关于深化医药卫生体制改革的意见》也明确要求切断药品销售与医生收入之间的利益链条，推动“阳光采购”和处方透明化。专家指出，根治“以药养医”顽疾，需从制度层面加强监管，完善薪酬激励机制，同时提升医务人员职业操守教育。只有构建清正廉洁的医疗环境，才能真正保障患者权益和医疗体系的公信力。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/12490.html